Insights

Life Sciences spotlight: GenomeKey

By SETsquared-Bristol / 6th March 2025

Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at a glance: Market sector: Life Sciences Location: Bristol Number of employees: 25 Amount of funding raised: Over £16m Company growth status: Commercialisation Let’s start with GenomeKey’s…

Healthtech spotlight: SoleSense

By SETsquared-Bristol / 18th September 2024

A year on from SoleSense’s Best Elevator Pitch award at our flagship Tech-Xpo showcase, we had a chat with Founder and CEO, Caz Icke, to hear her story. SoleSense at a glance: Market sector: Healthtech Location: Bristol Number of employees: 3 Company growth status: Pre-seed Let’s start with SoleSense’s elevator pitch SoleSense is a wearable digital system…

Healthtech spotlight: Jack Fertility

By SETsquared-Bristol / 24th June 2024

Jack Fertility has recently launched its £500K fundraising campaign to bring the world’s first home-to-lab sperm test kit to market. We had a chat with Co-founders, Lily Elsner and Nick Shipley, to hear their story… Jack Fertility at a glance: Start date: 2022 Market sector: Healthtech Location: Oxford Number of employees: 3 Amount of funding raised: £125k + government…

Climatetech spotlight: Fathom

By SETsquared-Bristol / 20th May 2024

Fathom, a global leader in flood and climate risk, has recently announced its significant acquisition to Swiss Re. We had a chat with Co-founder, Dr Andrew Smith, to hear his story… Fathom at a glance: Start date: Incorporated 2013 Market sector: Insurance/Climatetech Location: Bristol/London Number of employees: 55 Amount of funding raised: £5m seed funding Company growth…

Amutri: Revolutionising 3D visualisation

By SETsquared-Bristol / 3rd April 2024

Following Amutri’s £1 million raise in grant and equity funding, we had a chat with CEO, Michael Calver and Product Manager, Masayuki Kishi, to hear their story… Amutri at a glance:  Let’s start with Amutri’s elevator pitch Amutri is building a revolutionary 3D Visualisation product that turns Computer-aided design (CAD) and Building Information Modelling (BIM) files into…

Green transport spotlight: Dash

By SETsquared-Bristol / 7th March 2024

Dash has recently launched its pilot for a green transport solution. We had a chat with Co-founder, Omar Mahamed, to hear his story… Dash at a glance:  Let’s start with Dash’s elevator pitch At Dash, we are building an eco-friendly vehicle sharing service that provides our communities with an affordable solution to vehicle ownership. We believe that…

Siloton: Photonics technology to prevent sight loss

By SETsquared-Bristol / 6th June 2023

Following our member company Siloton’s £470k raise, which will further fund its diagnostic imaging technology to prevent sight loss, we had a chat with Co-founder and CEO, Alasdair Price, to hear his story… Siloton key facts Start date: 1 April 2020 Market sector: Healthtech Location: Bristol Company growth status: Seed Stage In your own words, what does Siloton do? Siloton…

Milbotix: Transforming dementia care with SmartSocks™

By SETsquared-Bristol / 4th May 2023

Following our company Milbotix’s recent investment from Alzheimer’s Society and £1.15m in non-dilutive funding awards, we had a chat with CEO, Dr Zeke Steer, to hear his story… Milbotix key facts Start date: 24 February 2020 Market sector: Healthtech/wearables/IoT Location: Bristol and Oxford Number of employees: 8 Company growth status: Startup Milbotix is partnered with the UK Dementia Research Institute and University…

Ethical Equity: A funding revolution for fair access to capital

By SETsquared-Bristol / 27th March 2023

We had a chat with Ethical Equity and AI Simulator Founder, Ali Kazmi, to hear his story… Ethical Equity key facts Start date: 13 Aug 2019 Market sector: Fintech Location: Bristol Number of employees:  5 core members Company growth status: Growth In your own words what does Ethical Equity do? Ethical Equity’s raison d’être is to improve…